Study of HDM1002 in people with and without liver problems
This trial tests a medicine called HDM1002 in people who have different levels of liver function. It aims to see how the liver affects the drug and if it is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You must weigh at least 50 kg (if male) or 40 kg (if female).
- Your body mass index (BMI) must be between 19 and 32.
- If you have normal liver function, you must not have taken any medication in the last 28 days (or longer).
- If you have liver problems, you must not have had serious complications like bleeding or very low blood sugar in the last 3 months.
- You cannot have a history of certain thyroid cancers or pancreatitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study tests how two experimental drugs (AZD9550 and AZD6234) work in people with different levels of liver function. The goal is to understand whether liver disease changes how the body processes these medications, which may help doctors safely treat patients with liver problems in the future.
This study tests how a new medicine, BI 3000202, is absorbed into the blood. It includes people with different levels of liver function (normal, mild, moderate, or severe) to see if liver problems affect how the medicine works.
This trial tests a new medication, HDM1005, to help people with obesity or overweight who do not have diabetes lose weight. It is for Chinese adults who have a high body mass index (BMI) or a BMI above 24 with weight-related health problems like high blood pressure or fatty liver.
This trial studies how a new medicine, HDM1005, may change the way the body absorbs or processes some common medications like metformin, atorvastatin, warfarin, and digoxin. It may help doctors understand if HDM1005 can be taken safely with other drugs.
This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.
This study tests how a new drug called HDM1002 interacts with common diabetes medications (metformin, empagliflozin) and other drugs like warfarin and valsartan. If you are a generally healthy adult (age 18-45) with a higher BMI, this trial helps ensure the new drug is safe when taken with other medicines.
Hear when a new Hepatic Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.